PACB earnings: next report 2026-08-03, real EPS beat/miss history, analyst consensus Buy, P/E -3.21. Updated 2026-07-23.
Pacific Biosciences of California (PACB) Research Hub
Pacific Biosciences of California (PACB) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 1.3 USD (+0.78%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -3.21, market cap 0.43B. This hub links to the full technical, earnings and options research available for PACB.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.3 USD (+0.78%) |
| 52-week range | 1.1 USD – 1.84 USD |
| Trend regime | Range |
| 14-day RSI | 56.2 (Bullish) |
| Trailing P/E | -3.21 |
| Market cap | 0.43B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-03 |
Available research for PACB
Covered Call on PACB: how it works, illustrative setup around the real 1.3 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PACB: how it works, illustrative setup around the real 1.3 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PACB: how it works, illustrative setup around the real 1.3 USD price, max profit/loss, breakeven and when to use it. Educational.
PACB technical analysis: range, last 1.3 USD, RSI 56.2, 52w range 1.1 USD–1.84 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is PACB in?
Pacific Biosciences of California (PACB) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is PACB in an uptrend or downtrend?
As of 2026-09-11, PACB is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PACB's trailing P/E ratio?
PACB's trailing P/E is -3.21, with a market cap of 0.43B. See the earnings research page for full valuation detail.
When does PACB next report earnings?
PACB is next scheduled to report earnings on 2026-08-03, with a consensus EPS estimate of -0.128 USD.